Zoetis Inc. (ZTS)
NYSE: ZTS · Real-Time Price · USD
164.43
-0.74 (-0.45%)
At close: Mar 18, 2025, 4:00 PM
163.67
-0.76 (-0.47%)
After-hours: Mar 18, 2025, 6:40 PM EST
Zoetis Revenue
In the year 2024, Zoetis had annual revenue of $9.26B with 8.33% growth. Zoetis had revenue of $2.32B in the quarter ending December 31, 2024, with 4.70% growth.
Revenue (ttm)
$9.26B
Revenue Growth
+8.33%
P/S Ratio
8.07
Revenue / Employee
n/a
Employees
n/a
Market Cap
73.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.26B | 712.00M | 8.33% |
Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ZTS News
- 5 days ago - Zoetis: Focusing On The High Margin Segments - Seeking Alpha
- 7 days ago - Zoetis Inc. (ZTS) CFO Wetteny Joseph Hosts Barclays 27th Annual Global Healthcare (Transcript) - Seeking Alpha
- 15 days ago - My Top 15 High-Growth Dividend Stocks For March 2025 - Seeking Alpha
- 18 days ago - Zoetis Inc. (ZTS) BofA Securities 2025 Animal Health Summit (Transcript) - Seeking Alpha
- 26 days ago - Zoetis to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - US grants conditional clearance to Zoetis' bird flu vaccine for poultry - Reuters
- 4 weeks ago - Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus - Business Wire
- 4 weeks ago - Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity - Seeking Alpha